Revised Medical Criteria for Evaluating HIV Infection, 14409-14411 [E8-5022]
Download as PDF
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Proposed Rules
significant economic impact on a
substantial number of small entities
under the criteria of the Regulatory
Flexibility Act.
The FAA’s authority to issue rules
regarding aviation safety is found in
Title 49 of the United States Code.
Subtitle I, Section 106 describes the
authority of the FAA Administrator.
Subtitle VII, Aviation Programs,
describes in more detail the scope of the
agency’s authority.
This rulemaking is promulgated
under the authority described in
Subtitle VII, Part A, Subpart I, Section
40103. Under that section, the FAA is
charged with prescribing regulations to
assign the use of airspace necessary to
ensure the safety of aircraft and the
efficient use of airspace. This regulation
is within the scope of that authority as
it proposes to establish Class E airspace
at Philippi, WV.
List of Subjects in 14 CFR Part 71
Airspace, Incorporation by reference,
Navigation (air).
The Proposed Amendment
In consideration of the foregoing, the
Federal Aviation Administration
proposes to amend 14 CFR part 71 as
follows:
PART 71—DESIGNATION OF CLASS A,
B, C, D, AND E AIRSPACE AREAS;
AIRWAYS; ROUTES; AND REPORTING
POINTS
1. The authority citation for part 71
continues to read as follows:
Authority: 49 U.S.C. 106(g); 40103, 40113,
40120; E.O. 10854, 24 FR 9565, 3 CFR, 1959–
1963 Comp., p. 389.
§ 71.1
[Amended]
2. The incorporation by reference in
14 CFR 71.1 of Federal Aviation
Administration Order 7400.9R, Airspace
Designations and Reporting Points,
signed August 15, 2007, and effective
September 15, 2007, is amended as
follows:
Paragraph 6005 Class E Airspace Areas
Extending Upward From 700 Feet or More
Above the Surface of the Earth
rwilkins on PROD1PC63 with PROPOSALS
*
*
*
*
*
AEA WV E5 Philippi, WV [New]
Philippi/Barbour County Regional Airport,
WV
(Lat. 39°09′58″ N., long. 80°03′45″ W.)
That airspace extending upward from 700
feet above the surface of the Earth within a
6.6-mile radius of Philippi/Barbour County
Regional Airport.
*
*
*
VerDate Aug<31>2005
*
*
16:08 Mar 17, 2008
Jkt 214001
Issued in College Park, Georgia, on
February 25, 2008.
Mark D. Ward,
Manager, System Support Group Eastern
Service Center.
[FR Doc. E8–5170 Filed 3–17–08; 8:45 am]
BILLING CODE 4910–13–M
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA 2007–0082]
RIN 0960–AG67
Revised Medical Criteria for Evaluating
HIV Infection
Social Security Administration.
Advance Notice of Proposed
Rulemaking.
AGENCY:
ACTION:
SUMMARY: In a separate notice in today’s
edition of the Federal Register, we are
publishing final rules revising the
criteria we use to evaluate immune
system disorders, found in sections
14.00 and 114.00 of the Listing of
Impairments in appendix 1 to subpart P
of part 404 of our regulations (the
listings). In those rules, we indicate that
we will issue an Advance Notice of
Proposed Rulemaking (ANPRM) inviting
public comments on how we might
update and revise listings 14.08 and
114.08, our listings for evaluating HIV
infection. We are now requesting your
comments and suggestions about
possible revisions to those listings.
After we have considered your
comments and suggestions, other
information about advances in medical
knowledge, treatment, and methods of
evaluating HIV infection, and our
program experience using the current
listings, we will determine whether we
should revise listings 14.08 and 114.08.
If we propose specific revisions to the
listings, we will publish a Notice of
Proposed Rulemaking (NPRM) in the
Federal Register.
DATES: To be sure that your comments
are considered, we must receive them
no later than May 19, 2008.
ADDRESSES: You may submit comments
by any of the following methods.
Regardless of which method you
choose, to ensure that we can associate
your comments with the correct
regulation for consideration, you must
state that your comments refer to Docket
No. SSA–2007–0082:
• Federal eRulemaking Portal at
https://www.regulations.gov. (This is the
preferred method for submitting your
comments.) In the Search Documents
section, select ‘‘Social Security
Administration’’ from the agency drop-
PO 00000
Frm 00010
Fmt 4702
Sfmt 4702
14409
down menu, then click ‘‘submit.’’ In the
Docket ID Column, locate SSA–2007–
0082 and then click ‘‘Add Comments’’
in the ‘‘Comments Add/Due By’’
column.
• Telefax to (410) 966–2830.
• Letter to the Commissioner of
Social Security, P.O. Box 17703,
Baltimore, Maryland 21235–7703.
• Deliver your comments to the Office
of Regulations, Social Security
Administration, 922 Altmeyer Building,
6401 Security Boulevard, Baltimore,
Maryland 21235–6401, between 8 a.m.
and 4:30 p.m. on regular business days.
Comments are posted on the Federal
eRulemaking portal, or you may inspect
them on regular business days by
making arrangements with the contact
person shown in this preamble.
FOR FURTHER INFORMATION CONTACT: Paul
Scott, Office of Compassionate
Allowances and Listings Improvement,
Social Security Administration, 4422
Annex Building, 6401 Security
Boulevard, Baltimore, MD 21235–6401,
(410) 966–1192, for information about
this notice. For information on
eligibility or filing for benefits, call our
national toll-free number, 1–800–772–
1213 or TTY 1–800–325–0778, or visit
our Internet site, Social Security Online,
at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Electronic Version
The electronic file of this document is
available on the date of publication in
the Federal Register at https://
www.gpoaccess.gov/fr/.
What is the purpose of this ANPRM?
The purpose of this ANPRM is to give
you an opportunity to send us
comments and suggestions on whether
and how we might update and revise
listings 14.08 and 114.08, our listings
for evaluating HIV infection. In a
separate notice in today’s edition of the
Federal Register, we are publishing
final rules revising the criteria we use to
evaluate immune system disorders,
found in sections 14.00 and 114.00 of
the listings. We proposed changes to
listings 14.08 and 114.08 when we
published our NPRM on August 4, 2006
(71 FR 44432 (2006)), and we received
some public comments suggesting
changes to those listings. Although the
final rules that we are are publishing
today include changes to listings 14.08
and 114.08, the criteria in these listings
are not substantively different from the
criteria in our proposed rules and our
current rules. We have decided to
publish this ANPRM partly because we
need additional information and partly
because we believe that some of the
E:\FR\FM\18MRP1.SGM
18MRP1
14410
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Proposed Rules
changes suggested in the public
comments were too extensive to include
in a final rule without giving the public
a chance to comment on them.
Which rules are we inviting comments
about?
We are considering whether and how
to update and revise listings 14.08 and
114.08. You can find the revised rules
for listing sections 14.00 and 114.00 in
a separate notice that we are publishing
in today’s edition of the Federal
Register.
What should you comment about?
We are specifically interested in any
comments and suggestions you have on
how we might update and revise listings
14.08 and 114.08. The issues we want
your comments to address are:
• Should we add, change, or remove
any of the criteria in listings 14.08 and
114.08?
• If so, what revisions do you think
we should make?
Will we respond to your comments
from this notice?
We invite comments and suggestions
from anyone who has an interest in the
rules we use to evaluate claims for
benefits filed by persons who have HIV
infection. We are interested in getting
comments and suggestions from persons
who apply for or receive benefits from
us, members of the general public,
advocates and organizations who
represent people who have HIV
infection, State agencies that make
disability determinations for us, experts
in the evaluation of HIV infection, and
researchers.
We will not respond directly to
comments you send us in response to
this notice. However, after we consider
your comments along with other
information, such as medical research
and other information about advances in
medical knowledge, treatment, and
methods of evaluating HIV infection and
our program experience, we will decide
whether and how to revise listings 14.08
and 114.08. If we propose revisions to
those listings, we will publish an NPRM
in the Federal Register. In accordance
with the usual rulemaking procedures
we follow, if we publish an NPRM, you
will have a chance to comment on any
proposed revisions to listings 14.08 and
114.08, and we will summarize and
If you file a claim under . . .
And you are . . .
title II ..................................................................
An adult or child ...............................................
title XVI ..............................................................
title XVI ..............................................................
An individual age 18 or older ...........................
An individual under age 18 ..............................
How do we decide whether you are
disabled?
your physical or mental ability to do
basic work activities, we will find that
you are not disabled. If you do, we will
go on to step 3.
3. Do you have an impairment(s) that
meets or medically equals the severity
of an impairment in the listings? If you
do, and the impairment(s) meets the
duration requirement, we will find that
you are disabled. If you do not, we will
go to step 4.
4. Do you have the residual functional
capacity (RFC) to do your past relevant
work? If you do, we will find that you
are not disabled. If you do not, we will
go on to step 5.
5. Does your impairment(s) prevent
you from doing any other work that
exists in significant numbers in the
national economy, considering your
RFC, age, education, and work
experience? If it does, and it meets the
duration requirement, we will find that
you are disabled. If it does not, we will
find that you are not disabled.
rwilkins on PROD1PC63 with PROPOSALS
Who should send us comments and
suggestions?
If you are applying for benefits under
title II of the Act, or if you are an adult
applying for payments under title XVI of
the Act, we use a five-step ‘‘sequential
evaluation process’’ to decide whether
you are disabled. We describe this fivestep process in our regulations at
§§ 404.1520 and 416.920. We follow the
five steps in order and stop as soon as
we can make a determination or
decision. The steps are:
1. Are you working, and is the work
you are doing SGA? If you are working
and the work you are doing is SGA, we
will find that you are not disabled,
regardless of your medical condition or
your age, education, and work
experience. If you are not, we will go on
to step 2.
2. Do you have a ‘‘severe’’
impairment? If you do not have an
impairment or combination of
impairments that significantly limits
VerDate Aug<31>2005
16:08 Mar 17, 2008
Jkt 214001
PO 00000
Frm 00011
Fmt 4702
respond to the significant comments on
the NPRM in the preamble to any final
rules.
Other Information
Who can get disability benefits?
Under title II of the Social Security
Act (the Act), we provide for the
payment of disability benefits if you are
disabled and belong to one of the
following three groups:
• Workers insured under the Act,
• Children of insured workers, and
• Widows, widowers, and surviving
divorced spouses (see § 404.336) of
insured workers.
Under title XVI of the Act, we provide
for Supplemental Security Income (SSI)
payments on the basis of disability if
you are disabled and have limited
income and resources.
How do we define disability?
Under both the title II and title XVI
programs, disability must be the result
of any medically determinable physical
or mental impairment or combination of
impairments that is expected to result in
death or which has lasted or is expected
to last for a continuous period of at least
12 months. Our definitions of disability
are shown in the following table:
Disability means you have a medically determinable impairment(s) as described above
that results in . . .
Sfmt 4702
the inability to do any substantial gainful activity (SGA).
the inability to do any SGA.
marked and severe functional limitations.
We use a different sequential
evaluation process for children who
apply for payments based on disability
under SSI. If you are already receiving
benefits, we also use a different
sequential evaluation process when we
decide whether your disability
continues. See §§ 404.1594, 416.924,
416.994, and 416.994a of our
regulations. However, all of these
processes include steps at which we
consider whether your impairment(s)
meets or medically equals one of our
listings.
What are the listings?
The listings are examples of
impairments that we consider severe
enough to prevent you as an adult from
doing any gainful activity. If you are a
child seeking SSI payments based on
disability, the listings describe
impairments that we consider severe
enough to result in marked and severe
functional limitations. Although the
listings are contained only in appendix
E:\FR\FM\18MRP1.SGM
18MRP1
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Proposed Rules
1 to subpart P of part 404 of our
regulations, we incorporate them by
reference in the SSI program in
§ 416.925 of our regulations, and apply
them to claims under both title II and
title XVI of the Act.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
How do we use the listings?
[Docket No. 2008N–0011]
The listings are in two parts. There
are listings for adults (part A) and for
children (part B). If you are an
individual age 18 or over, we apply the
listings in part A when we assess your
claim, and we do not use the listings in
part B.
If you are an individual under age 18,
we first use the criteria in part B of the
listings. If the criteria in part B do not
apply, we may use the criteria in part A
when those criteria give appropriate
consideration to the effects of the
impairment(s) in children. (See
§§ 404.1525 and 416.925.)
If your impairment(s) does not meet
any listing, we will also consider
whether it medically equals any listing,
that is, whether it is as medically severe
as an impairment in the listings. (See
§§ 404.1526 and 416.926.)
What if you do not have an
impairment(s) that meets or medically
equals a listing?
We use the listings only to decide that
you are disabled or that you are still
disabled. We will not deny your claim
or decide that you no longer qualify for
benefits because your impairment(s)
does not meet or medically equal a
listing. If you have a severe
impairment(s) that does not meet or
medically equal any listing, we may still
find you disabled based on other rules
in the ‘‘sequential evaluation process.’’
Likewise, we will not decide that your
disability has ended only because your
impairment(s) no longer meets or
medically equals a listing.
List of Subjects in 20 CFR Part 404
rwilkins on PROD1PC63 with PROPOSALS
Administrative practice and
procedure, Blind, Disability benefits,
Old-Age, Survivors and Disability
Insurance, Reporting and recordkeeping
requirements, Social Security.
Dated: January 15, 2008.
Michael J. Astrue,
Commissioner of Social Security.
[FR Doc. E8–5022 Filed 3–17–08; 8:45 am]
BILLING CODE 4191–02–P
VerDate Aug<31>2005
16:08 Mar 17, 2008
Jkt 214001
Food and Drug Administration
21 CFR Part 516
RIN 0910–AG03
Defining Small Number of Animals for
Minor Use Designation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Proposed rule.
SUMMARY: The designation provision of
the Minor Use and Minor Species
Animal Health Act of 2004 (MUMS act)
provides incentives to animal drug
sponsors to encourage drug
development and approval for minor
species and for minor uses in major
animal species. Congress provided a
statutory definition of ‘‘minor use’’ that
relied on the phrase ‘‘small number of
animals’’ to characterize such use. At
this time, FDA is proposing to amend
the implementing regulations of the
MUMS act. In response to Congress’
charge to the agency to further define
minor use, this amendment proposes a
specific ‘‘small number of animals’’ for
each of the seven major animal species
to be used in determining whether any
particular intended use in a major
species is a minor use.
DATES: Submit written or electronic
comments on the proposed rule by July
16, 2008. Submit comments regarding
information collection by April 17, 2008
to OMB (see ADDRESSES).
ADDRESSES: You may submit comments,
identified by Docket No. 2008N–0011
and RIN number 0910–AG03, by any of
the following methods:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Written Submissions
Submit written submissions in the
following ways:
• FAX: 301–827–6870.
• Mail/Hand delivery/Courier [For
paper, disk, or CD–ROM submissions]:
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
To ensure more timely processing of
comments, FDA is no longer accepting
comments submitted to the agency by email. FDA encourages you to continue
to submit electronic comments by using
the Federal eRulemaking Portal or the
PO 00000
Frm 00012
Fmt 4702
Sfmt 4702
14411
agency Web site, as described
previously, in the ADDRESSES portion of
this document under Electronic
Submissions.
Instructions: All submissions received
must include the agency name and
Docket No(s). and Regulatory
Information Number (RIN) (if a RIN
number has been assigned) for this
rulemaking. All comments received may
be posted without change to https://
www.regulations.gov, including any
personal information provided. For
additional information on submitting
comments, see the ‘‘Comments’’ heading
of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov and insert the
docket number(s), found in brackets in
the heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
Information Collection Provisions:
Submit written comments on the
information collection provisions to the
Office of Information and Regulatory
Affairs, Office of Management and
Budget (OMB).To ensure that comments
on the information collection are
received, OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Margaret Oeller, Center for Veterinary
Medicine (HFV–50), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9005, email: Margaret.Oeller@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
A. The Definition of Minor Use
The MUMS act (Public Law 108–282)
amended the Federal Food, Drug, and
Cosmetic Act (the act) to provide
incentives for the development of new
animal drugs for use in minor animal
species and for minor uses in major
animal species. The MUMS act defines
‘‘minor use’’ as ‘‘the intended use of a
drug in a major species for an indication
that occurs infrequently and in only a
small number of animals or in limited
geographical areas and in only a small
number of animals annually’’ (section
201(pp) of the act (21 U.S.C. 321(pp)).
The major species are cattle, horses,
swine, chickens, turkeys, dogs, and cats
(21 U.S.C. 321(nn)).
Prior to enactment of the MUMS act,
FDA defined minor use by regulation to
E:\FR\FM\18MRP1.SGM
18MRP1
Agencies
[Federal Register Volume 73, Number 53 (Tuesday, March 18, 2008)]
[Proposed Rules]
[Pages 14409-14411]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5022]
=======================================================================
-----------------------------------------------------------------------
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA 2007-0082]
RIN 0960-AG67
Revised Medical Criteria for Evaluating HIV Infection
AGENCY: Social Security Administration.
ACTION: Advance Notice of Proposed Rulemaking.
-----------------------------------------------------------------------
SUMMARY: In a separate notice in today's edition of the Federal
Register, we are publishing final rules revising the criteria we use to
evaluate immune system disorders, found in sections 14.00 and 114.00 of
the Listing of Impairments in appendix 1 to subpart P of part 404 of
our regulations (the listings). In those rules, we indicate that we
will issue an Advance Notice of Proposed Rulemaking (ANPRM) inviting
public comments on how we might update and revise listings 14.08 and
114.08, our listings for evaluating HIV infection. We are now
requesting your comments and suggestions about possible revisions to
those listings.
After we have considered your comments and suggestions, other
information about advances in medical knowledge, treatment, and methods
of evaluating HIV infection, and our program experience using the
current listings, we will determine whether we should revise listings
14.08 and 114.08. If we propose specific revisions to the listings, we
will publish a Notice of Proposed Rulemaking (NPRM) in the Federal
Register.
DATES: To be sure that your comments are considered, we must receive
them no later than May 19, 2008.
ADDRESSES: You may submit comments by any of the following methods.
Regardless of which method you choose, to ensure that we can associate
your comments with the correct regulation for consideration, you must
state that your comments refer to Docket No. SSA-2007-0082:
Federal eRulemaking Portal at https://www.regulations.gov.
(This is the preferred method for submitting your comments.) In the
Search Documents section, select ``Social Security Administration''
from the agency drop-down menu, then click ``submit.'' In the Docket ID
Column, locate SSA-2007-0082 and then click ``Add Comments'' in the
``Comments Add/Due By'' column.
Telefax to (410) 966-2830.
Letter to the Commissioner of Social Security, P.O. Box
17703, Baltimore, Maryland 21235-7703.
Deliver your comments to the Office of Regulations, Social
Security Administration, 922 Altmeyer Building, 6401 Security
Boulevard, Baltimore, Maryland 21235-6401, between 8 a.m. and 4:30 p.m.
on regular business days.
Comments are posted on the Federal eRulemaking portal, or you may
inspect them on regular business days by making arrangements with the
contact person shown in this preamble.
FOR FURTHER INFORMATION CONTACT: Paul Scott, Office of Compassionate
Allowances and Listings Improvement, Social Security Administration,
4422 Annex Building, 6401 Security Boulevard, Baltimore, MD 21235-6401,
(410) 966-1192, for information about this notice. For information on
eligibility or filing for benefits, call our national toll-free number,
1-800-772-1213 or TTY 1-800-325-0778, or visit our Internet site,
Social Security Online, at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Electronic Version
The electronic file of this document is available on the date of
publication in the Federal Register at https://www.gpoaccess.gov/fr/
index.html.
What is the purpose of this ANPRM?
The purpose of this ANPRM is to give you an opportunity to send us
comments and suggestions on whether and how we might update and revise
listings 14.08 and 114.08, our listings for evaluating HIV infection.
In a separate notice in today's edition of the Federal Register, we are
publishing final rules revising the criteria we use to evaluate immune
system disorders, found in sections 14.00 and 114.00 of the listings.
We proposed changes to listings 14.08 and 114.08 when we published our
NPRM on August 4, 2006 (71 FR 44432 (2006)), and we received some
public comments suggesting changes to those listings. Although the
final rules that we are are publishing today include changes to
listings 14.08 and 114.08, the criteria in these listings are not
substantively different from the criteria in our proposed rules and our
current rules. We have decided to publish this ANPRM partly because we
need additional information and partly because we believe that some of
the
[[Page 14410]]
changes suggested in the public comments were too extensive to include
in a final rule without giving the public a chance to comment on them.
Which rules are we inviting comments about?
We are considering whether and how to update and revise listings
14.08 and 114.08. You can find the revised rules for listing sections
14.00 and 114.00 in a separate notice that we are publishing in today's
edition of the Federal Register.
Who should send us comments and suggestions?
We invite comments and suggestions from anyone who has an interest
in the rules we use to evaluate claims for benefits filed by persons
who have HIV infection. We are interested in getting comments and
suggestions from persons who apply for or receive benefits from us,
members of the general public, advocates and organizations who
represent people who have HIV infection, State agencies that make
disability determinations for us, experts in the evaluation of HIV
infection, and researchers.
What should you comment about?
We are specifically interested in any comments and suggestions you
have on how we might update and revise listings 14.08 and 114.08. The
issues we want your comments to address are:
Should we add, change, or remove any of the criteria in
listings 14.08 and 114.08?
If so, what revisions do you think we should make?
Will we respond to your comments from this notice?
We will not respond directly to comments you send us in response to
this notice. However, after we consider your comments along with other
information, such as medical research and other information about
advances in medical knowledge, treatment, and methods of evaluating HIV
infection and our program experience, we will decide whether and how to
revise listings 14.08 and 114.08. If we propose revisions to those
listings, we will publish an NPRM in the Federal Register. In
accordance with the usual rulemaking procedures we follow, if we
publish an NPRM, you will have a chance to comment on any proposed
revisions to listings 14.08 and 114.08, and we will summarize and
respond to the significant comments on the NPRM in the preamble to any
final rules.
Other Information
Who can get disability benefits?
Under title II of the Social Security Act (the Act), we provide for
the payment of disability benefits if you are disabled and belong to
one of the following three groups:
Workers insured under the Act,
Children of insured workers, and
Widows, widowers, and surviving divorced spouses (see
Sec. 404.336) of insured workers.
Under title XVI of the Act, we provide for Supplemental Security
Income (SSI) payments on the basis of disability if you are disabled
and have limited income and resources.
How do we define disability?
Under both the title II and title XVI programs, disability must be
the result of any medically determinable physical or mental impairment
or combination of impairments that is expected to result in death or
which has lasted or is expected to last for a continuous period of at
least 12 months. Our definitions of disability are shown in the
following table:
------------------------------------------------------------------------
Disability means
you have a
medically
determinable
If you file a claim under . . . And you are . . . impairment(s) as
described above
that results in .
. .
------------------------------------------------------------------------
title II........................ An adult or child. the inability to
do any
substantial
gainful activity
(SGA).
title XVI....................... An individual age the inability to
18 or older. do any SGA.
title XVI....................... An individual marked and severe
under age 18. functional
limitations.
------------------------------------------------------------------------
How do we decide whether you are disabled?
If you are applying for benefits under title II of the Act, or if
you are an adult applying for payments under title XVI of the Act, we
use a five-step ``sequential evaluation process'' to decide whether you
are disabled. We describe this five-step process in our regulations at
Sec. Sec. 404.1520 and 416.920. We follow the five steps in order and
stop as soon as we can make a determination or decision. The steps are:
1. Are you working, and is the work you are doing SGA? If you are
working and the work you are doing is SGA, we will find that you are
not disabled, regardless of your medical condition or your age,
education, and work experience. If you are not, we will go on to step
2.
2. Do you have a ``severe'' impairment? If you do not have an
impairment or combination of impairments that significantly limits your
physical or mental ability to do basic work activities, we will find
that you are not disabled. If you do, we will go on to step 3.
3. Do you have an impairment(s) that meets or medically equals the
severity of an impairment in the listings? If you do, and the
impairment(s) meets the duration requirement, we will find that you are
disabled. If you do not, we will go to step 4.
4. Do you have the residual functional capacity (RFC) to do your
past relevant work? If you do, we will find that you are not disabled.
If you do not, we will go on to step 5.
5. Does your impairment(s) prevent you from doing any other work
that exists in significant numbers in the national economy, considering
your RFC, age, education, and work experience? If it does, and it meets
the duration requirement, we will find that you are disabled. If it
does not, we will find that you are not disabled.
We use a different sequential evaluation process for children who
apply for payments based on disability under SSI. If you are already
receiving benefits, we also use a different sequential evaluation
process when we decide whether your disability continues. See
Sec. Sec. 404.1594, 416.924, 416.994, and 416.994a of our regulations.
However, all of these processes include steps at which we consider
whether your impairment(s) meets or medically equals one of our
listings.
What are the listings?
The listings are examples of impairments that we consider severe
enough to prevent you as an adult from doing any gainful activity. If
you are a child seeking SSI payments based on disability, the listings
describe impairments that we consider severe enough to result in marked
and severe functional limitations. Although the listings are contained
only in appendix
[[Page 14411]]
1 to subpart P of part 404 of our regulations, we incorporate them by
reference in the SSI program in Sec. 416.925 of our regulations, and
apply them to claims under both title II and title XVI of the Act.
How do we use the listings?
The listings are in two parts. There are listings for adults (part
A) and for children (part B). If you are an individual age 18 or over,
we apply the listings in part A when we assess your claim, and we do
not use the listings in part B.
If you are an individual under age 18, we first use the criteria in
part B of the listings. If the criteria in part B do not apply, we may
use the criteria in part A when those criteria give appropriate
consideration to the effects of the impairment(s) in children. (See
Sec. Sec. 404.1525 and 416.925.)
If your impairment(s) does not meet any listing, we will also
consider whether it medically equals any listing, that is, whether it
is as medically severe as an impairment in the listings. (See
Sec. Sec. 404.1526 and 416.926.)
What if you do not have an impairment(s) that meets or medically equals
a listing?
We use the listings only to decide that you are disabled or that
you are still disabled. We will not deny your claim or decide that you
no longer qualify for benefits because your impairment(s) does not meet
or medically equal a listing. If you have a severe impairment(s) that
does not meet or medically equal any listing, we may still find you
disabled based on other rules in the ``sequential evaluation process.''
Likewise, we will not decide that your disability has ended only
because your impairment(s) no longer meets or medically equals a
listing.
List of Subjects in 20 CFR Part 404
Administrative practice and procedure, Blind, Disability benefits,
Old-Age, Survivors and Disability Insurance, Reporting and
recordkeeping requirements, Social Security.
Dated: January 15, 2008.
Michael J. Astrue,
Commissioner of Social Security.
[FR Doc. E8-5022 Filed 3-17-08; 8:45 am]
BILLING CODE 4191-02-P